ClearBridge International Growth Fund Q1 2025 Commentary
Source: SeekingAlpha
2025-04-30 22:55:00 ET
Summary
- The MSCI EAFE Growth Index was up 2.13% while the MSCI EAFE Value Index, home to many of the companies expected to lead a resurgence in manufacturing activity, surged 11.56%.
- Stock selection in health care and industrials held back performance with particular weakness among biopharmaceutical holdings Novo Nordisk and Argenx.
- Inflation in the Eurozone has remained below 3% for 18 months, giving the European Central Bank greater latitude than the U.S. Federal Reserve in continuing to cut interest rates.
Key Takeaways
Read the full article on Seeking Alpha
For further details see:
ClearBridge International Growth Fund Q1 2025 Commentary
Argen X SE
NASDAQ: ARGNF
ARGNF Trading
2.56% G/L:
$814.94 Last:
2 Volume:
$814.94 Open:
ARGNF Latest News
March 06, 2026 01:00:00 am
argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline
February 26, 2026 01:00:00 am
argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
February 26, 2026 12:30:00 am
argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
ARGNF Stock Data
$50,515,067,402
49,738,024
N/A
478
N/A
Biotechnology & Life Sciences
Healthcare
NL
Amsterdam
